Some aspects of evolutionary pharmacology.
D000109:Acetylcholine / Q000502:physiology; D000255:Adenosine Triphosphate / Q000502:physiology; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D005075:Biological Evolution; D003714:Denervation; D004285:Dogs; D005399:Fishes; D005730:Ganglionic Blockers / Q000494:pharmacology; D007448:Invertebrates; D051379:Mice; D009132:Muscles / Q000294:innervation; D009474:Neurons / Q000502:physiology; D018377:Neurotransmitter Agents / Q000502:physiology; D010600:Pharmacology; D011506:Proteins / Q000502:physiology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects; D013569:Synapses / Q000502:physiology*; D013570:Synaptic Membranes / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects; D014714:Vertebrates
D005730:Ganglionic Blockers; D018377:Neurotransmitter Agents; D011506:Proteins; D000644:Quaternary Ammonium Compounds; D011950:Receptors, Cholinergic; D000255:Adenosine Triphosphate; D000109:Acetylcholine